{"schema_version":"secwatch.filing_event.v1","accession":"0000877860-24-000048","form_type":"8-K","ticker":"NHI","cik":"0000877860","company_name":"NATIONAL HEALTH INVESTORS INC","filed_at":"2024-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.257598+00:00","generated_at":"2026-06-02T22:41:51.294100+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NHI Q1 Normalized FFO $1.12/share vs $1.11 YoY; full-year guidance raised","bullets":["Q1 diluted EPS $0.71 (vs $0.79); NAREIT FFO $1.10 (vs $1.16); Normalized FFO $1.12 (vs $1.11).","Full-year 2024 guidance raised: NAREIT FFO $4.36-$4.41; Normalized FFO $4.37-$4.43; Normalized FAD $196.7-$199.2M.","Collected $2.3M deferred rent in Q1; Bickford annual rent reset to $34.5M up from $31.4M.","SHOP NOI $2.9M (+$1.0M YoY); occupancy at SLC 83.1%, Bickford 85.8%, SHOP 86.3% in March.","Net debt $1.1B; leverage 4.4x; $25M board-approved capex at ~8% yield; pipeline >$300M with LOIs >$100M at >8%."],"urls":{"canonical":"https://secwatch.observer/filing/0000877860-24-000048","json":"https://secwatch.observer/filing/0000877860-24-000048.json","markdown":"https://secwatch.observer/filing/0000877860-24-000048.md","text":"https://secwatch.observer/filing/0000877860-24-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000048/0000877860-24-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000048/nhi-20240506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T22:41:51.294100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec6e87f1495d2b30e04a31059e82d8d273fcdaee","claim":"NATIONAL HEALTH INVESTORS INC reported three months ended March 31, 2024 results: EPS $0.71. Guidance raised.","evidence_excerpt":"Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786024000048/0000877860-24-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"EPS","value":"$0.71"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}